New Patient Appointment or 214-645-8300


All Raksha Jain, M.D.


Beyond the lungs: How CFTR modulators benefit cystic fibrosis patients

Traditionally, patients with cystic fibrosis have been treated with inhaled medications that could affect the lungs with limited systemic effects. However, a relatively new set of drugs, CFTR modulators, offer an oral alternative with the potential to slow the progression of the disease for up to 90 percent of patients.